–Declares get-go dividend for a major biotechnology caller

–Earnings cliff as increased costs set-back receipts amplification

–Still, results measure expectations; troupe raises 2011 expectations

(Adds psychoanalyst response in the 7th paragraph, society remark start in the THIRTEENTH paragraph and updates inventory toll)

NEW YORK -(Dow Jones)- Amgen Inc. (AMGN) stated its outset quarterly dividend, of 28 cents a part, a long-anticipated movement that reflects the matureness of the formerly high-growth biotechnology troupe.

The revealing came as the Thou Oaks, Kalif., society reported a 2.7% downslope in second-quarter salary on higher maturation and selling …

Tags:

This entry was posted on Saturday, July 30th, 2011 at 2:30 and is filed under Pills. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.